Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Head and Neck Cancer

  Free Subscription


Articles published in Ann Surg

Retrieve available abstracts of 125 articles:
HTML format



Single Articles


    May 2022
  1. OKUNO K, Tokunaga M, Kinugasa Y, Baba H, et al
    A Transcriptomic Liquid Biopsy Assay for Predicting Resistance to Neoadjuvant Therapy in Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2022 May 13. pii: 00000658-990000000-00001.
    PubMed     Abstract available


  2. CLAASSEN L, Hannink G, Luyer MDP, Ainsworth AP, et al
    Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study.
    Ann Surg. 2022;275:911-918.
    PubMed     Abstract available


  3. FRANSEN LFC, Janssen THJB, Aarnoudse M, Nieuwenhuijzen GAP, et al
    Direct Oral Feeding After a Minimally Invasive Esophagectomy: A Single-Center Prospective Cohort Study.
    Ann Surg. 2022;275:919-923.
    PubMed     Abstract available


    April 2022
  4. SHEN Y, Zhang Y, He M, Fang Y, et al
    Advancing Gastroscope From Intraluminal to Extraluminal Dissection: Primary Experience of Laparo-gastroscopic Esophagectomy.
    Ann Surg. 2022;275:e659-e663.
    PubMed     Abstract available


  5. SUH YS, Na D, Lee JS, Chae J, et al
    Comprehensive Molecular Characterization of Adenocarcinoma of the Gastroesophageal Junction Between Esophageal and Gastric Adenocarcinomas.
    Ann Surg. 2022;275:706-717.
    PubMed     Abstract available


  6. KAMARAJAH SK, Phillips AW, Hanna GB, Low DE, et al
    Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma?: A Propensity-matched Analysis.
    Ann Surg. 2022;275:700-705.
    PubMed     Abstract available


    March 2022
  7. KUPPUSAMY MK, Low DE
    Evaluation of International Contemporary Operative Outcomes and Management Trends Associated With Esophagectomy: A 4-Year Study of >6000 Patients Using ECCG Definitions and the Online Esodata Database.
    Ann Surg. 2022;275:515-525.
    PubMed     Abstract available


  8. RAMAN V, Jawitz OK, Farrow NE, Voigt SL, et al
    The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:e562-e567.
    PubMed     Abstract available


    February 2022
  9. LI S, Ai Q, Liang H, Liu H, et al
    Nonintubated Robotic-assisted Thoracic Surgery for Tracheal/Airway Resection and Reconstruction: Technique Description and Preliminary Results.
    Ann Surg. 2022;275:e534-e536.
    PubMed     Abstract available


  10. MARKAR SR, Zaninotto G, Castoro C, Johar A, et al
    Lasting Symptoms After Esophageal Resection (LASER): European Multicenter Cross-sectional Study.
    Ann Surg. 2022;275:e392-e400.
    PubMed     Abstract available


  11. RUCKER AJ, Raman V, Jawitz OK, Voigt SL, et al
    The Impact of Adjuvant Therapy on Survival After Esophagectomy for Node-negative Esophageal Adenocarcinoma.
    Ann Surg. 2022;275:348-355.
    PubMed     Abstract available


    January 2022
  12. ELLIOTT JA, Markar SR, Klevebro F, Johar A, et al
    An International Multicenter Study Exploring Whether Surveillance After Esophageal Cancer Surgery Impacts Oncological and Quality of Life Outcomes (ENSURE).
    Ann Surg. 2022 Jan 27. pii: 00000658-900000000-93088.
    PubMed     Abstract available


  13. SANABRIA A, Betancourt C, Sanchez JG, Garcia C, et al
    Prophylactic Central Neck Lymph Node Dissection in Low-Risk Thyroid Carcinoma Patients Does not Decrease the Incidence of Locoregional Recurrence: A Meta-Analysis of Randomized Trials.
    Ann Surg. 2022 Jan 24. pii: 00000658-900000000-93112.
    PubMed     Abstract available


  14. BOSHIER PR, Klevebro F, Savva KV, Waller A, et al
    Assessment of Health Related Quality of Life and Digestive Symptoms in Long-term, Disease Free Survivors After Esophagectomy.
    Ann Surg. 2022;275:e140-e147.
    PubMed     Abstract available


  15. HARRIS A, Butterworth J, Boshier PR, MacKenzie H, et al
    Development of a Reliable Surgical Quality Assurance System for 2-stage Esophagectomy in Randomized Controlled Trials.
    Ann Surg. 2022;275:121-130.
    PubMed     Abstract available


    December 2021
  16. OSHIKIRI T, Numasaki H, Oguma J, Toh Y, et al
    Prognosis of Patients with Esophageal Carcinoma following Routine Thoracic Duct Resection: A Propensity-matched Analysis of 12,237 Patients based on the Comprehensive Registry of Esophageal Cancer in Japan.
    Ann Surg. 2021 Dec 14. pii: 00000658-900000000-93155.
    PubMed     Abstract available


  17. CLAASSEN L, Hannink G, van Workum F, Rosman C, et al
    Response to the Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics a Retrospective Multi-national Cohort Study".
    Ann Surg. 2021;274:e930.
    PubMed    


  18. PRASAD P, Phillips AW
    Comment on "Learning Curves of Ivor Lewis Totally Minimally Invasive Esophagectomy by Hospital and Surgeon Characteristics: A Retrospective Multinational Cohort Study".
    Ann Surg. 2021;274:e929-e930.
    PubMed    


  19. HOLSCHER AH, Bollschweiler E
    Comment on "Is Local Endoscopic Resection a Viable Therapeutic Option for Early Clinical Stage T1a and T1b Esophageal Adenocarcinoma? A Propensity-matched Analysis".
    Ann Surg. 2021;274:e916-e917.
    PubMed    


  20. NABHAN FA
    Comment on "Barriers to the Use of Active Surveillance for Thyroid Cancer: Results of a Physicians Survey".
    Ann Surg. 2021;274:e880-e881.
    PubMed    


  21. SHEN H, Liu Q
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e805-e806.
    PubMed    


  22. LU J, Wu D, Huang C
    Comment on "The Relationship Between Lymph Node Ratio and Survival Benefit With Adjuvant Chemotherapy in Node-positive Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e845-e846.
    PubMed    


  23. RAJA S, Blackstone EH
    Response to the Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e757-e758.
    PubMed    


  24. KUROKAWA Y, Doki Y, Takeuchi H, Kitagawa Y, et al
    Response to the Comment on: Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors.
    Ann Surg. 2021;274:e806-e807.
    PubMed    


  25. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e741-e742.
    PubMed    


  26. ZHANG G, Zhang H, Li Q, Li J, et al
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e740-e741.
    PubMed    


  27. KHAW RA, Kamarajah SK, Phillips AW
    Comments on "Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma".
    Ann Surg. 2021;274:e756-e757.
    PubMed    


  28. MORIS D, Tsilimigras DI, Schizas D
    Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e744-e745.
    PubMed    


  29. FRANSEN LFC, Luyer MDP
    Response to the Comment on "The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study".
    Ann Surg. 2021;274:e745-e746.
    PubMed    


  30. KUROKAWA Y, Takeuchi H, Doki Y, Kitagawa Y, et al
    Response to the Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e682-e683.
    PubMed    


  31. ZHAO B, Liang R, Li G
    Comment on "Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors".
    Ann Surg. 2021;274:e681-e682.
    PubMed    


  32. VAN DER WILK BJ, van Lanschot JJB
    Response to the Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e697-e698.
    PubMed    


  33. GUTSCHOW CA
    Response to the Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e686.
    PubMed    


  34. MOLENA D, Louie BE, Demeester SR
    Comment on "Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer".
    Ann Surg. 2021;274:e695-e696.
    PubMed    


  35. KAMARAJAH SK, Griffiths EA
    Comment on "Anastomotic Techniques and Associated Morbidity in Total Minimally Invasive Transthoracic Esophagectomy: Results From the EsoBenchmark Database".
    Ann Surg. 2021;274:e685-e686.
    PubMed    


  36. YONEKURA H, Nakamori Y, Takeda C, Kawasaki Y, et al
    Comment on "The Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672.
    PubMed    


  37. FRANSEN LFC, Berkelmans GHK, Asti E, Henegouwen MIVB, et al
    The Effect of Postoperative Complications After Minimally Invasive Esophagectomy on Long-term Survival: An International Multicenter Cohort Study.
    Ann Surg. 2021;274:e1129-e1137.
    PubMed     Abstract available


  38. SAKAMOTO T, Fujiogi M, Yasunaga H
    Response to the Comment on "Effect of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer".
    Ann Surg. 2021;274:e672-e673.
    PubMed    


  39. LENG X, He W, Yang H, Chen Y, et al
    Prognostic Impact of Postoperative Lymph Node Metastases After Neoadjuvant Chemoradiotherapy for Locally Advanced Squamous Cell Carcinoma of Esophagus: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2021;274:e1022-e1029.
    PubMed     Abstract available


  40. MARET-OUDA J, Santoni G, Wahlin K, Artama M, et al
    Esophageal Adenocarcinoma After Antireflux Surgery in a Cohort Study From the 5 Nordic Countries.
    Ann Surg. 2021;274:e535-e540.
    PubMed     Abstract available


  41. SCHOPPMANN SF, Jomrich G
    Response to the Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e669-e670.
    PubMed    


  42. SUN L, Liang H, Feng Y
    Comment on "High Systemic Immune-inflammation Index Is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma".
    Ann Surg. 2021;274:e668-e669.
    PubMed    


  43. VAN DER WILK BJ, Noordman BJ, Neijenhuis LKA, Nieboer D, et al
    Active Surveillance Versus Immediate Surgery in Clinically Complete Responders After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: A Multicenter Propensity Matched Study.
    Ann Surg. 2021;274:1009-1016.
    PubMed     Abstract available


    November 2021
  44. HIRANO Y, Kaneko H, Konishi T, Itoh H, et al
    Impact of Body Mass Index on Major Complications, Multiple Complications, In-hospital Mortality, and Failure to Rescue Following Esophagectomy for Esophageal Cancer: A Nationwide Inpatient Database Study in Japan.
    Ann Surg. 2021 Nov 23. pii: 00000658-900000000-93169.
    PubMed     Abstract available


  45. LIU F, Yang W, Yang W, Xu R, et al
    Minimally Invasive or Open Esophagectomy for Treatment of Resectable Esophageal Squamous Cell Carcinoma? Answer from a Real-World Multicenter Study.
    Ann Surg. 2021 Nov 11. pii: 00000658-900000000-93196.
    PubMed     Abstract available


  46. HE Z, Liu F, Yang W, Ke Y, et al
    Response to: Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93201.
    PubMed    


  47. HUANG S, Wang S, Gao Z, Qiao G, et al
    Comment on "Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data".
    Ann Surg. 2021 Nov 9. pii: 00000658-900000000-93198.
    PubMed    


  48. KALFF MC, Gottlieb-Vedi E, Verhoeven RHA, van Laarhoven HWM, et al
    Presentation, Treatment, and Prognosis of Esophageal Carcinoma in a Nationwide Comparison of Sweden and the Netherlands.
    Ann Surg. 2021;274:743-750.
    PubMed     Abstract available


  49. HERTAULT H, Gandon A, Behal H, Legault G, et al
    Incidence and Risk Factors for Diaphragmatic Herniation Following Esophagectomy for Cancer.
    Ann Surg. 2021;274:758-765.
    PubMed     Abstract available


  50. MULLER PC, Morell B, Vetter D, Raptis DA, et al
    Preemptive Endoluminal Vacuum Therapy to Reduce Morbidity After Minimally Invasive Ivor Lewis Esophagectomy: Including a Novel Grading System for Postoperative Endoscopic Assessment of GI-Anastomoses.
    Ann Surg. 2021;274:751-757.
    PubMed     Abstract available


  51. DONLON NE, Kammili A, Roopnarinesingh R, Davern M, et al
    FLOT-regimen Chemotherapy and Transthoracic en bloc Resection for Esophageal and Junctional Adenocarcinoma.
    Ann Surg. 2021;274:814-820.
    PubMed     Abstract available


  52. WONG IYH, Zhang RQ, Tsang RKY, Kwok JYY, et al
    Improving Outcome of Superior Mediastinal Lymph Node Dissection During Esophagectomy: A Novel Approach Combining Continuous and Intermittent Recurrent Laryngeal Nerve Monitoring.
    Ann Surg. 2021;274:736-742.
    PubMed     Abstract available


    October 2021
  53. RAJA S, Rice TW, Murthy SC, Ahmad U, et al
    Value of Lymphadenectomy in Patients Receiving Neoadjuvant Therapy for Esophageal Adenocarcinoma.
    Ann Surg. 2021;274:e320-e327.
    PubMed     Abstract available


    September 2021
  54. LEE Y, Samarasinghe Y, Lee MH, Thiru L, et al
    Role of Adjuvant Therapy in Esophageal Cancer Patients after Neoadjuvant Therapy and Esophagectomy: A Systematic Review and Meta-Analysis.
    Ann Surg. 2021 Sep 29. pii: 00000658-900000000-93257.
    PubMed     Abstract available


  55. KLOFT M, Ruisch JE, Raghuram G, Emmerson J, et al
    Prognostic Significance of Negative Lymph Node Long Axis in Esophageal Cancer: Results From the Randomized Controlled UK MRC OE02 Trial.
    Ann Surg. 2021 Sep 13. pii: 00000658-900000000-93281.
    PubMed     Abstract available


  56. VOETEN DM, Gisbertz SS, Ruurda JP, Wilschut JA, et al
    Overall Volume Trends in Esophageal Cancer Surgery Results From the Dutch Upper Gastrointestinal Cancer Audit.
    Ann Surg. 2021;274:449-458.
    PubMed     Abstract available


  57. KAMEL MK, Harrison S, Lee B, Port JL, et al
    Extended Lymphadenectomy Improves Survival After Induction Chemoradiation for Esophageal Cancer: A Propensity Matched Analysis of the National Cancer Database.
    Ann Surg. 2021 Sep 1. pii: 00000658-900000000-93285.
    PubMed     Abstract available


  58. LIMBERG J, Ullmann TM, Stefanova D, Buicko JL, et al
    Does Aggressive Variant Histology Without Invasive Features Predict Overall Survival in Papillary Thyroid Cancer?: A National Cancer Database Analysis.
    Ann Surg. 2021;274:e276-e281.
    PubMed     Abstract available


  59. CLARK JM, Cooke DT, Hashimi H, Chin D, et al
    Do the 2018 Leapfrog Group Minimal Hospital and Surgeon Volume Thresholds for Esophagectomy Favor Specific Patient Demographics?
    Ann Surg. 2021;274:e220-e229.
    PubMed     Abstract available


    August 2021
  60. FRANSEN LFC, Luyer MDP
    Response to the Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial) an International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196-e197.
    PubMed    


  61. MORIS D, Cerullo M
    Comment on "Direct Oral Feeding After Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial".
    Ann Surg. 2021;274:e196.
    PubMed    


  62. SAKAMOTO T, Fujiogi M, Matsui H, Fushimi K, et al
    Comparing Perioperative Mortality and Morbidity of Minimally Invasive Esophagectomy Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Retrospective Analysis.
    Ann Surg. 2021;274:324-330.
    PubMed     Abstract available


    July 2021
  63. NOMA T, Makino T, Ohshima K, Sugimura K, et al
    Immunoscore Signatures in Surgical Specimens and Tumor-Infiltrating Lymphocytes in Pretreatment Biopsy Predict Treatment Efficacy and Survival in Esophageal Cancer.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93382.
    PubMed     Abstract available


  64. DEFIZE IL, Goense L, Borggreve AS, Mook S, et al
    Risk Factors for Tumor Positive Resection Margins After Neoadjuvant Chemoradiotherapy for Esophageal Cancer: Results from the Dutch Upper GI Cancer Audit: A Nationwide Population-Based Study.
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93365.
    PubMed     Abstract available


  65. VOETEN DM, Busweiler LAD, van der Werf LR, Wijnhoven BPL, et al
    Outcomes of Esophagogastric Cancer Surgery during eight Years of Surgical Auditing by the Dutch Upper Gastrointestinal Cancer Audit (DUCA).
    Ann Surg. 2021 Jul 29. pii: 00000658-900000000-93364.
    PubMed     Abstract available


  66. DEMEESTER SR
    Response to the Comment on "The Prevalence of Lymph Node Metastases in Patients With T1 Esophageal Adenocarcinoma A Retrospective Review of Esophagectomy Specimens".
    Ann Surg. 2021;274:e106-e107.
    PubMed    


  67. KUROKAWA Y, Takeuchi H, Doki Y, Mine S, et al
    Mapping of Lymph Node Metastasis From Esophagogastric Junction Tumors: A Prospective Nationwide Multicenter Study.
    Ann Surg. 2021;274:120-127.
    PubMed     Abstract available


    June 2021
  68. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Hedberg J, et al
    Extent of Lymphadenectomy and Long-Term Survival in Esophageal Cancer.
    Ann Surg. 2021 Jun 25. pii: 00000658-900000000-93462.
    PubMed     Abstract available


  69. YANG Y, Li B, Yi J, Hua R, et al
    Robot-Assisted Versus Conventional Minimally Invasive Esophagectomy for Resectable Esophageal Squamous Cell Carcinoma: Early Results of a Multicenter Randomized Controlled Trial: the RAMIE Trial.
    Ann Surg. 2021 Jun 18. pii: 00000658-900000000-93478.
    PubMed     Abstract available


  70. WANG BY, Lin CH, Wu SC, Chen HS, et al
    Survival Comparison Between Open and Thoracoscopic Upfront Esophagectomy in Patients with Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2021 Jun 10. pii: 00000658-900000000-93505.
    PubMed     Abstract available


  71. YANG W, Liu F, Xu R, Yang W, et al
    Is adjuvant therapy a better option for esophageal squamous cell carcinoma patients treated with esophagectomy? A prognosis prediction model based on multicenter real-world data.
    Ann Surg. 2021 Jun 2. pii: 00000658-900000000-93529.
    PubMed     Abstract available


  72. KELLY RJ, Ansari AM, Miyashita T, Zahurak M, et al
    Targeting the Hedgehog Pathway Using Itraconazole to Prevent Progression of Barrett's Esophagus to Invasive Esophageal Adenocarcinoma.
    Ann Surg. 2021;273:e206-e213.
    PubMed     Abstract available


    May 2021
  73. DU J, Shen X
    Comment on "Genomic Alteration and Immunity-Implications In Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93540.
    PubMed    


  74. DU J, Guan W, Shen X
    Comment on "Circulating Tumor Cells-New Indicator For Clinical Staging Of Patients With Esophageal Cancer".
    Ann Surg. 2021 May 24. pii: 00000658-900000000-93536.
    PubMed    


  75. KOSUMI K, Baba Y, Baba H
    Response to Comment on "Genomic Alteration and Immunity-Implications in Esophageal Cancer".
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93548.
    PubMed    


  76. REEH M
    Response to Comment on "Circulating Tumor Cells - New Indicator for Clinical Staging of Patients with Esophageal Cancer" by Wenxian Guan.
    Ann Surg. 2021 May 19. pii: 00000658-900000000-93547.
    PubMed    


  77. VAN DER WILK BJ, Eyck BM, Hofstetter WL, Ajani JA, et al
    Chemoradiotherapy followed by Active Surveillance Versus Standard Esophagectomy for Esophageal Cancer: A Systematic Review and Individual Patient Data Meta-Analysis.
    Ann Surg. 2021 May 11. doi: 10.1097/SLA.0000000000004930.
    PubMed     Abstract available


  78. XIE SH, Santoni G, Malberg K, Lagergren P, et al
    Prediction Model of Long-term Survival After Esophageal Cancer Surgery.
    Ann Surg. 2021;273:933-939.
    PubMed     Abstract available


    April 2021
  79. HARADA K, Hwang H, Wang X, Abdelhakeem A, et al
    Frequency and Implications of Paratracheal Lymph Node Metastases in Resectable Esophageal or Gastroesophageal Junction Adenocarcinoma.
    Ann Surg. 2021;273:751-757.
    PubMed     Abstract available


  80. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a Simple Infective Complication? (ANNSURG-D21-00007).
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004873.
    PubMed    


  81. BABA Y, Kosumi K, Baba H
    Comments on "The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?"
    Ann Surg. 2021 Apr 1. doi: 10.1097/SLA.0000000000004879.
    PubMed    


    March 2021
  82. LEVY J, Gupta V, Coburn NG
    Response to "Comment on Textbook Outcome and Survival in Patients with Gastric Cancer: An Analysis of the Population Registry of Esophageal and Stomach Tumours of Ontario (PRESTO)".
    Ann Surg. 2021 Mar 5. pii: 00000658-900000000-93662.
    PubMed    


  83. JAWITZ NG, Raman V, Jawitz OK, Shimpi RA, et al
    Utilization Trends and Volume-Outcomes Relationship of Endoscopic Resection for Early Stage Esophageal Cancer.
    Ann Surg. 2021 Mar 3. doi: 10.1097/SLA.0000000000004834.
    PubMed     Abstract available


  84. JOMRICH G, Paireder M, Kristo I, Baierl A, et al
    High Systemic Immune-Inflammation Index is an Adverse Prognostic Factor for Patients With Gastroesophageal Adenocarcinoma.
    Ann Surg. 2021;273:532-541.
    PubMed     Abstract available


    February 2021
  85. GUO X, Wang Z, Yang H, Mao T, et al
    Impact of Lymph Node Dissection on Survival after Neoadjuvant Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma: From the Results of NEOCRTEC5010, a Randomized Multicenter Study.
    Ann Surg. 2021 Feb 10. pii: 00000658-900000000-93700.
    PubMed     Abstract available


    January 2021
  86. GOTTLIEB-VEDI E, Kauppila JH, Mattsson F, Lindblad M, et al
    Long-term survival in esophageal cancer after minimally invasive esophagectomy compared to open esophagectomy.
    Ann Surg. 2021 Jan 20. pii: 00000658-900000000-93754.
    PubMed     Abstract available


  87. KUO JH, Lee JA
    The Adoption of Ultrasound-guided Radiofrequency Ablation of Thyroid Nodules in the United States.
    Ann Surg. 2021;273:e10-e12.
    PubMed    


    December 2020
  88. KALFF MC, Fransen LFC, de Groot EM, Gisbertz SS, et al
    Long-Term Survival After Minimally Invasive Versus Open Esophagectomy for Esophageal Cancer: A Nationwide Propensity-Score Matched Analysis.
    Ann Surg. 2020;Publish Ahead of Print.
    PubMed     Abstract available


  89. MAO QJ, Yan PJ, Liang YL
    Comment on "Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study".
    Ann Surg. 2020 Dec 3. doi: 10.1097/SLA.0000000000004158.
    PubMed    


    November 2020
  90. XUE FS, Xue ZJ, Wan L
    Comment on "Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004614.
    PubMed    


  91. MURPHY CF, Dunne T, Elliott JA, Kamarajah SK, et al
    Response to "Comment on Acute Kidney Injury after Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004609.
    PubMed    


  92. MAKINO T, Hagi T, Doki Y
    Response to Comment on: "Pathological Regression of Lymph Nodes Better Predicts Long-Term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004605.
    PubMed    


  93. CHEN D, Wen J, Zheng Y, Chen Y, et al
    Comment on "Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery".
    Ann Surg. 2020 Nov 17. doi: 10.1097/SLA.0000000000004606.
    PubMed    


  94. RAFTERY NB, Murphy CF, Donohoe CL, O'Connell B, et al
    The Complexity of Defining Postoperative Pneumonia following Esophageal Cancer Surgery: A Spectrum of Lung Injury rather than a simple Infective complication?
    Ann Surg. 2020 Nov 12. doi: 10.1097/SLA.0000000000004546.
    PubMed     Abstract available


  95. DONLON NE, Elliott JA, Donohoe CL, Murphy CF, et al
    Adverse Biology in Adenocarcinoma of the Esophagus and Esophagogastric Junction Impacts Survival and Response to Neoadjuvant Therapy Independent of Anatomic Subtype.
    Ann Surg. 2020;272:814-819.
    PubMed     Abstract available


  96. VOETEN DM, van der Werf LR, Wijnhoven BPL, van Hillegersberg R, et al
    Failure to Cure in Patients Undergoing Surgery for Esophageal Carcinoma: Hospital of Surgery Influences Prospects for Cure: A Nation-wide Cohort Study.
    Ann Surg. 2020;272:744-750.
    PubMed     Abstract available


    October 2020
  97. SHIN DW, Kim HK, Cho J, Lee G, et al
    Conditional Survival of Patients Who Underwent Curative Resection for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2020 Oct 19. doi: 10.1097/SLA.0000000000004473.
    PubMed     Abstract available


  98. MATSUDA S, Kawakubo H, Okamura A, Takahashi K, et al
    Distribution of Residual Disease and Recurrence Patterns in Pathological Responders After Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma.
    Ann Surg. 2020 Oct 16. doi: 10.1097/SLA.0000000000004436.
    PubMed     Abstract available


  99. SUGIMURA K, Miyata H, Tanaka K, Makino T, et al
    Multicenter Randomized Phase 2 Trial Comparing Chemoradiotherapy and Docetaxel Plus 5-Fluorouracil and Cisplatin (DCF) Chemotherapy as Initial Induction Therapy for Subsequent Conversion Surgery in Patients with Clinical T4b Esophageal Cancer: Short-t
    Ann Surg. 2020 Oct 15. doi: 10.1097/SLA.0000000000004564.
    PubMed     Abstract available


  100. CHEN H
    Follicular Neoplasms of the Thyroid: Can They Be Observed?
    Ann Surg. 2020;272:628.
    PubMed    


    September 2020
  101. YOSHIDA N, Eto K, Kurashige J, Izumi D, et al
    Comprehensive Analysis of Multiple Primary Cancers in Patients with Esophageal Squamous Cell Carcinoma Undergoing Esophagectomy.
    Ann Surg. 2020 Sep 15. doi: 10.1097/SLA.0000000000004490.
    PubMed     Abstract available


  102. SOSA JA
    When the World Around Changes While you are Doing Great Science.
    Ann Surg. 2020;272:504-505.
    PubMed    


  103. SIPPEL RS, Robbins SE, Poehls JL, Pitt SC, et al
    A Randomized Controlled Clinical Trial: No Clear Benefit to Prophylactic Central Neck Dissection in Patients With Clinically Node Negative Papillary Thyroid Cancer.
    Ann Surg. 2020;272:496-503.
    PubMed     Abstract available


    August 2020
  104. VON HOLZEN U, Schmidt S, Hayoz S, Steffen T, et al
    Surgical Outcomes After Neoadjuvant Chemoradiation Followed by Curative Surgery in Patients With Esophageal Cancer: An Intergroup Phase lll Trial of the Swiss Group for Clinical Cancer Research (SAKK 75/08).
    Ann Surg. 2020 Aug 26. doi: 10.1097/SLA.0000000000004334.
    PubMed     Abstract available


  105. YASUDA T, Nishiki K, Hiraki Y, Kato H, et al
    Phase II Adjuvant Cancer-specific Vaccine Therapy for Esophageal Cancer Patients Curatively Resected After Preoperative Therapy With Pathologically Positive Nodes; Possible Significance of Tumor Immune Microenvironment in its Clinical Effects.
    Ann Surg. 2020 Aug 26. doi: 10.1097/SLA.0000000000003880.
    PubMed     Abstract available


  106. NILSSON K, Klevebro F, Rouvelas I, Lindblad M, et al
    Surgical Morbidity and Mortality From the Multicenter Randomized Controlled NeoRes II Trial: Standard Versus Prolonged Time to Surgery After Neoadjuvant Chemoradiotherapy for Esophageal Cancer.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004340.
    PubMed     Abstract available


  107. WONG IYH, Lam KO, Zhang RQ, Chan WWL, et al
    Neoadjuvant Chemoradiotherapy Using Cisplatin and 5-Fluorouracil (PF) Versus Carboplatin and Paclitaxel (CROSS Regimen) for Esophageal Squamous Cell Carcinoma (ESCC): A Propensity Score-Matched Study.
    Ann Surg. 2020 Aug 21. doi: 10.1097/SLA.0000000000004329.
    PubMed     Abstract available


  108. HARADA K, Wu CC, Wang X, Mizrak Kaya D, et al
    Total Lesion Glycolysis Assessment Identifies a Patient Fraction With a High Cure Rate Among Esophageal Adenocarcinoma Patients Treated With Definitive Chemoradiation.
    Ann Surg. 2020;272:311-318.
    PubMed     Abstract available


    July 2020
  109. MURPHY CF, Dunne T, Elliott JA, Kamarajah SK, et al
    Acute Kidney Injury After Esophageal Cancer Surgery: Incidence, Risk Factors, and Impact on Oncologic Outcomes.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004146.
    PubMed     Abstract available


  110. FAIZ Z, Kats-Ugurlu G, Mul VEM, Karrenbeld A, et al
    Locoregional Residual Esophageal Cancer after Neo-adjuvant Chemoradiotherapy and Surgery Regarding Anatomic Site and Radiation Target Fields: A Histopathologic Evaluation Study.
    Ann Surg. 2020 Jul 24. doi: 10.1097/SLA.0000000000004242.
    PubMed     Abstract available


  111. HAGI T, Makino T, Yamasaki M, Yamashita K, et al
    Pathological Regression of Lymph Nodes Better Predicts Long-term Survival in Esophageal Cancer Patients Undergoing Neoadjuvant Chemotherapy Followed by Surgery.
    Ann Surg. 2020 Jul 14. doi: 10.1097/SLA.0000000000004238.
    PubMed     Abstract available


  112. YOSHIDA N, Baba H
    Response to the Letter to the Editor for "Clinical Importance of Mean Corpuscular Volume as a Prognostic Marker After Esophagectomy for Esophageal Cancer: A Retrospective Study".
    Ann Surg. 2020 Jul 9. doi: 10.1097/SLA.0000000000004128.
    PubMed    


  113. CARTY SE, Ohori NP, Hilko DA, McCoy KL, et al
    The Clinical Utility of Molecular Testing in the Management of Thyroid Follicular Neoplasms (Bethesda IV Nodules).
    Ann Surg. 2020 Jul 8. doi: 10.1097/SLA.0000000000004130.
    PubMed     Abstract available


  114. LENSCHOW C, Schragle S, Kircher S, Lorenz K, et al
    Clinical Presentation, Treatment, and Outcome of Parathyroid Carcinoma: Results of the NEKAR Retrospective International Multicenter Study.
    Ann Surg. 2020 Jul 7. doi: 10.1097/SLA.0000000000004144.
    PubMed     Abstract available


  115. YANO M, Sugimura K, Miyata H, Motoori M, et al
    Randomized Comparison of Gastric Tube Reconstruction With and Without Duodenal Diversion Plus Roux-en-Y Anastomosis After Esophagectomy.
    Ann Surg. 2020;272:48-54.
    PubMed     Abstract available


  116. NOBEL TB, Livschitz J, Eljalby M, Janjigian YY, et al
    Unique Considerations for Females Undergoing Esophagectomy.
    Ann Surg. 2020;272:113-117.
    PubMed     Abstract available


    June 2020
  117. VAN DER WERF LR, Busweiler LAD, van Sandick JW, van Berge Henegouwen MI, et al
    Reporting National Outcomes After Esophagectomy and Gastrectomy According to the Esophageal Complications Consensus Group (ECCG).
    Ann Surg. 2020;271:1095-1101.
    PubMed     Abstract available


  118. NISHIKAWA K, Fujita T, Yuda M, Tanaka Y, et al
    Quantitative Assessment of Blood Flow in the Gastric Conduit With Thermal Imaging for Esophageal Reconstruction.
    Ann Surg. 2020;271:1087-1094.
    PubMed     Abstract available


    May 2020
  119. SAEKI H, Jogo T, Kawazoe T, Kamori T, et al
    RAD51 Expression as a Biomarker to Predict Efficacy of Preoperative Therapy and Survival for Esophageal Squamous Cell Carcinoma: A Large-cohort Observational Study (KSCC1307).
    Ann Surg. 2020 May 29. doi: 10.1097/SLA.0000000000003975.
    PubMed     Abstract available


  120. KAMARAJAH SK, Phillips AW, Hanna GB, Low D, et al
    Definitive Chemoradiotherapy Compared to Neoadjuvant Chemoradiotherapy With Esophagectomy for Locoregional Esophageal Cancer: National Population-Based Cohort Study.
    Ann Surg. 2020 May 19. doi: 10.1097/SLA.0000000000003941.
    PubMed     Abstract available


    April 2020
  121. WHITE C, Weinstein MC, Fingeret AL, Randolph GW, et al
    Is Less More? A Microsimulation Model Comparing Cost-effectiveness of the Revised American Thyroid Association's 2015 to 2009 Guidelines for the Management of Patients With Thyroid Nodules and Differentiated Thyroid Cancer.
    Ann Surg. 2020;271:765-773.
    PubMed     Abstract available


  122. SCHWAMEIS K, Zehetner J, Green KM, DeMeester SR, et al
    Workload, Recurrence, Quality of Life and Long-term Efficacy of Endoscopic Therapy for High-grade Dysplasia and Intramucosal Esophageal Adenocarcinoma.
    Ann Surg. 2020;271:701-708.
    PubMed     Abstract available


    March 2020
  123. CLARK OH
    Thyroid Nodule Guidelines.
    Ann Surg. 2020;271:411.
    PubMed    


    January 2020
  124. BERKELMANS GHK, Fransen LFC, Dolmans-Zwartjes ACP, Kouwenhoven EA, et al
    Direct Oral Feeding Following Minimally Invasive Esophagectomy (NUTRIENT II trial): An International, Multicenter, Open-label Randomized Controlled Trial.
    Ann Surg. 2020;271:41-47.
    PubMed     Abstract available


  125. VAN WORKUM F, Slaman AE, van Berge Henegouwen MI, Gisbertz SS, et al
    Propensity Score-Matched Analysis Comparing Minimally Invasive Ivor Lewis Versus Minimally Invasive Mckeown Esophagectomy.
    Ann Surg. 2020;271:128-133.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Head and Neck Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: